Michael Jeng

3.7k total citations
92 papers, 1.8k citations indexed

About

Michael Jeng is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Michael Jeng has authored 92 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 32 papers in Genetics and 23 papers in Oncology. Recurrent topics in Michael Jeng's work include Hemoglobinopathies and Related Disorders (22 papers), Vascular Malformations and Hemangiomas (17 papers) and Histiocytic Disorders and Treatments (14 papers). Michael Jeng is often cited by papers focused on Hemoglobinopathies and Related Disorders (22 papers), Vascular Malformations and Hemangiomas (17 papers) and Histiocytic Disorders and Treatments (14 papers). Michael Jeng collaborates with scholars based in United States, Germany and Canada. Michael Jeng's co-authors include Elliott Vichinsky, Winfred C. Wang, Carlos Rodríguez‐Galindo, James H. Feusner, Wendy Wong, Nina Holland, Paul Harmatz, Paurene Duramad, Ruchira Sood and James L. Zehnder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Jeng

89 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Jeng United States 27 795 494 335 289 271 92 1.8k
Fatma Gümrük Türkiye 23 817 1.0× 497 1.0× 170 0.5× 178 0.6× 179 0.7× 200 2.0k
Jennifer Schneiderman United States 15 732 0.9× 360 0.7× 283 0.8× 136 0.5× 180 0.7× 45 1.9k
David L. Becton United States 26 852 1.1× 321 0.6× 199 0.6× 181 0.6× 335 1.2× 61 1.9k
Michel De Bandt France 28 506 0.6× 310 0.6× 283 0.8× 263 0.9× 146 0.5× 81 2.7k
Nongnuch Sirachainan Thailand 22 835 1.1× 551 1.1× 246 0.7× 81 0.3× 194 0.7× 136 1.6k
José Carlos Jaime‐Pérez Mexico 25 1.3k 1.6× 472 1.0× 173 0.5× 170 0.6× 408 1.5× 182 2.2k
Onorina Berardicurti Italy 31 827 1.0× 204 0.4× 383 1.1× 316 1.1× 254 0.9× 88 2.6k
John Lazarchick United States 25 883 1.1× 309 0.6× 285 0.9× 94 0.3× 228 0.8× 135 2.0k
Georges E. Rivard Canada 29 1.8k 2.2× 394 0.8× 304 0.9× 225 0.8× 151 0.6× 70 2.9k
Ron Ram Israel 26 1.1k 1.4× 388 0.8× 94 0.3× 183 0.6× 695 2.6× 139 2.3k

Countries citing papers authored by Michael Jeng

Since Specialization
Citations

This map shows the geographic impact of Michael Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jeng more than expected).

Fields of papers citing papers by Michael Jeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jeng. The network helps show where Michael Jeng may publish in the future.

Co-authorship network of co-authors of Michael Jeng

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Jeng. A scholar is included among the top collaborators of Michael Jeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Jeng. Michael Jeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velikina, Julia, Lu Mao, Ruiyang Zhao, et al.. (2024). Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T. Magnetic Resonance in Medicine. 93(1). 330–340.
3.
Karpel, Hannah, Ellen J. Spartz, Theresa Willett, et al.. (2020). Hypoferritinemia and iron deficiency in youth with pediatric acute-onset neuropsychiatric syndrome. Pediatric Research. 89(6). 1477–1484. 6 indexed citations
4.
Kreimer, Sara, et al.. (2020). Venous malformations. Seminars in Pediatric Surgery. 29(5). 150976–150976. 18 indexed citations
5.
Barclay, Sarah, Valerie L. Luks, John B. McIntyre, et al.. (2018). A somatic activating NRAS variant associated with kaposiform lymphangiomatosis. Genetics in Medicine. 21(7). 1517–1524. 87 indexed citations
6.
7.
Shafiq, Mājid, Maurice L. Druzin, Michael Jeng, et al.. (2016). Pregnancy Complicated by Gorham–Stout Disease and Refractory Chylothorax. American Journal of Perinatology Reports. 6(4). e355–e358. 4 indexed citations
8.
Fontaine, Magali J., et al.. (2011). Disseminated intravascular coagulation due to IgM‐mediated autoimmune hemolytic anemia. Pediatric Blood & Cancer. 57(2). 329–331. 7 indexed citations
9.
Hidalgo-Curtis, Claire, Jane F. Apperley, Michael Jeng, et al.. (2009). Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms. British Journal of Haematology. 148(2). 268–273. 6 indexed citations
10.
Gramatges, M. Monica, et al.. (2009). Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Pediatric Blood & Cancer. 53(1). 97–99. 23 indexed citations
11.
Nadeau, Kari C., et al.. (2008). Idiopathic neutropenia of childhood is associated with Fas/FasL expression. Clinical Immunology. 129(3). 438–447. 5 indexed citations
12.
Rodríguez‐Galindo, Carlos, Michael Jeng, Phuong Khuu, M. Beth McCarville, & Sima Jeha. (2008). Clofarabine in refractory Langerhans cell histiocytosis. Pediatric Blood & Cancer. 51(5). 703–706. 22 indexed citations
13.
Sood, Ruchira, Wendy Wong, Jason Gotlib, Michael Jeng, & James L. Zehnder. (2007). Gene expression and pathway analysis of immune thrombocytopenic purpura. British Journal of Haematology. 140(1). 99–103. 23 indexed citations
14.
Fung, Ellen B., Paul Harmatz, Phillip Lee, et al.. (2006). Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia versus sickle‐cell disease. British Journal of Haematology. 135(4). 574–582. 133 indexed citations
15.
Hankins, Jane S., Michael Jeng, Sylvia C. Harris, et al.. (2005). Chronic Transfusion Therapy for Children With Sickle Cell Disease and Recurrent Acute Chest Syndrome. Journal of Pediatric Hematology/Oncology. 27(3). 158–161. 41 indexed citations
16.
Howard, Scott C., et al.. (2004). Natural history of moderate aplastic anemia in children. Pediatric Blood & Cancer. 43(5). 545–551. 42 indexed citations
17.
Jeng, Michael, Patricia Adams‐Graves, Thad A. Howard, et al.. (2003). Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. American Journal of Hematology. 74(4). 243–248. 12 indexed citations
18.
Rodríguez‐Galindo, Carlos, et al.. (2003). Extranodal Rosai-Dorfman Disease in Children. Journal of Pediatric Hematology/Oncology. 26(1). 19–24. 51 indexed citations
19.
Jeng, Michael, James H. Feusner, Christine F. Skibola, & Elliott Vichinsky. (2002). Central venous catheter complications in sickle cell disease. American Journal of Hematology. 69(2). 103–108. 57 indexed citations
20.
Jeng, Michael, et al.. (2002). Pseudotumor Cerebri in Two Adolescents with Acquired Aplastic Anemia. Journal of Pediatric Hematology/Oncology. 24(9). 765–768. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026